Page last updated: 2024-11-02

phenobarbital and Cutaneous T-Cell Lymphoma

phenobarbital has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakai, C1
Takagi, T1
Oguro, M1
Tanabe, N1
Wakatsuki, S1

Other Studies

1 other study available for phenobarbital and Cutaneous T-Cell Lymphoma

ArticleYear
Erythroderma and marked atypical lymphocytosis mimicking cutaneous T-cell lymphoma probably caused by phenobarbital.
    Internal medicine (Tokyo, Japan), 1993, Volume: 32, Issue:2

    Topics: Dermatitis, Exfoliative; Diagnosis, Differential; Drug Eruptions; Humans; Lymphocytosis; Lymphoma, T

1993